Vanguard Fiduciary Trust
PYXS icon

Vanguard Fiduciary Trust’s Pyxis Oncology PYXS Stock Holding History

Vanguard Fiduciary Trust’s Portfolio PYXS Stock Details PYXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$912K Buy
302,986
+2,089
+0.7% +$3.99K ﹤0.01% 3062
2026
Q1 		$439K Buy
+300,897
New +$454K ﹤0.01% 3251

Other funds holding PYXS

GGI
GordonMD Global Investments Beverely Hills, California $207M AUM
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.49% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Fiduciary Trust's PYXS Position: Q2 2026 in Review

Vanguard Fiduciary Trust increased its Pyxis Oncology (PYXS) stake by 0.69% in Q2 2026, buying an estimated $3.99K and bringing the position to 302,986 shares worth $912K. The position accounts for ﹤0.01% of the portfolio, ranked #3062.

Vanguard Fiduciary Trust first reported a position in PYXS in Q1 2026 and has held it in 2 quarters since. 77 funds tracked by Wall St. Rank hold PYXS as of Q2 2026.

  • Vanguard Fiduciary Trust held 302,986 shares of Pyxis Oncology worth $912K as of Q2 2026.
  • Vanguard Fiduciary Trust bought 2,089 Pyxis Oncology shares in Q2 2026, an estimated $3.99K.
  • Pyxis Oncology made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #3062 holding.
  • Vanguard Fiduciary Trust first reported a position in Pyxis Oncology in Q1 2026 and has held it in 2 quarters since.
  • 77 funds tracked by Wall St. Rank held Pyxis Oncology as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.